137 related articles for article (PubMed ID: 18229688)
1. Analysis of MALDI-TOF mass spectrometry data for detection of glycan biomarkers.
Ressom HW; Varghese RS; Goldman L; Loffredo CA; Abdel-Hamid M; Kyselova Z; Mechref Y; Novotny M; Goldman R
Pac Symp Biocomput; 2008; ():216-27. PubMed ID: 18229688
[TBL] [Abstract][Full Text] [Related]
2. Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma.
Ressom HW; Varghese RS; Goldman L; An Y; Loffredo CA; Abdel-Hamid M; Kyselova Z; Mechref Y; Novotny M; Drake SK; Goldman R
J Proteome Res; 2008 Feb; 7(2):603-10. PubMed ID: 18189345
[TBL] [Abstract][Full Text] [Related]
3. Detection of hepatocellular carcinoma using glycomic analysis.
Goldman R; Ressom HW; Varghese RS; Goldman L; Bascug G; Loffredo CA; Abdel-Hamid M; Gouda I; Ezzat S; Kyselova Z; Mechref Y; Novotny MV
Clin Cancer Res; 2009 Mar; 15(5):1808-13. PubMed ID: 19223512
[TBL] [Abstract][Full Text] [Related]
4. Integrated peptide and glycan biomarker discovery using MALDI-TOF mass spectrometry.
Varghese RS; Goldman L; An Y; Loffredo CA; Abdel-Hamid M; Kyselova Z; Mechref Y; Novotny M; Drake SK; Goldman R; Ressom HW
Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():3791-4. PubMed ID: 19163537
[TBL] [Abstract][Full Text] [Related]
5. LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma.
Tsai TH; Wang M; Di Poto C; Hu Y; Zhou S; Zhao Y; Varghese RS; Luo Y; Tadesse MG; Ziada DH; Desai CS; Shetty K; Mechref Y; Ressom HW
J Proteome Res; 2014 Nov; 13(11):4859-68. PubMed ID: 25077556
[TBL] [Abstract][Full Text] [Related]
6. Peak selection from MALDI-TOF mass spectra using ant colony optimization.
Ressom HW; Varghese RS; Drake SK; Hortin GL; Abdel-Hamid M; Loffredo CA; Goldman R
Bioinformatics; 2007 Mar; 23(5):619-26. PubMed ID: 17237065
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipidomic fingerprinting to distinguish among hepatitis C-related hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis C using MALDI-TOF mass spectrometry: a pilot study.
Passos-Castilho AM; Lo Turco E; Ferraz ML; Matos C; Silva I; Parise E; Pilau E; Gozzo F; Granato C
J Gastrointestin Liver Dis; 2015 Mar; 24(1):43-9. PubMed ID: 25822433
[TBL] [Abstract][Full Text] [Related]
8. Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data.
Tang Z; Varghese RS; Bekesova S; Loffredo CA; Hamid MA; Kyselova Z; Mechref Y; Novotny MV; Goldman R; Ressom HW
J Proteome Res; 2010 Jan; 9(1):104-12. PubMed ID: 19764807
[TBL] [Abstract][Full Text] [Related]
9. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
10. LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.
Xiao JF; Varghese RS; Zhou B; Nezami Ranjbar MR; Zhao Y; Tsai TH; Di Poto C; Wang J; Goerlitz D; Luo Y; Cheema AK; Sarhan N; Soliman H; Tadesse MG; Ziada DH; Ressom HW
J Proteome Res; 2012 Dec; 11(12):5914-23. PubMed ID: 23078175
[TBL] [Abstract][Full Text] [Related]
11. Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Zhang J; Zhong Y; Zhang P; Du H; Shu J; Liu X; Zhang H; Guo Y; Jia Z; Niu L; Yang F; Li Z
Glycobiology; 2019 Mar; 29(3):242-259. PubMed ID: 30535277
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
[TBL] [Abstract][Full Text] [Related]
13. High-throughput quantitative profiling of serum N-glycome by MALDI-TOF mass spectrometry and N-glycomic fingerprint of liver fibrosis.
Kam RK; Poon TC; Chan HL; Wong N; Hui AY; Sung JJ
Clin Chem; 2007 Jul; 53(7):1254-63. PubMed ID: 17510303
[TBL] [Abstract][Full Text] [Related]
14. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
15. Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis.
Saito Y; Oba N; Nishinakagawa S; Mizuguchi Y; Kojima T; Nomura K; Nakatsura T
Oncol Rep; 2010 May; 23(5):1325-30. PubMed ID: 20372847
[TBL] [Abstract][Full Text] [Related]
16. Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis.
Ying X; Han SX; Wang JL; Zhou X; Jin GH; Jin L; Wang H; Wu L; Zhang J; Zhu Q
Diagn Pathol; 2013 Aug; 8():130. PubMed ID: 23915185
[TBL] [Abstract][Full Text] [Related]
17. Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification.
Cui J; Kang X; Dai Z; Huang C; Zhou H; Guo K; Li Y; Zhang Y; Sun R; Chen J; Li Y; Tang Z; Uemura T; Liu Y
J Cancer Res Clin Oncol; 2007 Nov; 133(11):825-34. PubMed ID: 17516088
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis.
Kamiyama T; Yokoo H; Furukawa J; Kurogochi M; Togashi T; Miura N; Nakanishi K; Kamachi H; Kakisaka T; Tsuruga Y; Fujiyoshi M; Taketomi A; Nishimura S; Todo S
Hepatology; 2013 Jun; 57(6):2314-25. PubMed ID: 23322672
[TBL] [Abstract][Full Text] [Related]
19. Parallel On-Target Derivatization for Mass Calibration and Rapid Profiling of
Zhao X; Huang Y; Ma G; Liu Y; Guo C; He Q; Wang H; Liao J; Pan Y
Anal Chem; 2020 Jan; 92(1):991-998. PubMed ID: 31829556
[TBL] [Abstract][Full Text] [Related]
20. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
